Inogen Inc (INGN)
7.05
+0.15
(+2.17%)
USD |
NASDAQ |
Apr 24, 16:00
7.06
+0.01
(+0.14%)
Pre-Market: 20:00
Inogen SG&A Expense (Quarterly): 50.43M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 50.43M |
September 30, 2023 | 43.10M |
June 30, 2023 | 41.52M |
March 31, 2023 | 47.30M |
December 31, 2022 | 29.86M |
September 30, 2022 | 48.51M |
June 30, 2022 | 43.07M |
March 31, 2022 | 43.23M |
December 31, 2021 | 40.58M |
September 30, 2021 | 37.56M |
June 30, 2021 | 34.54M |
March 31, 2021 | 37.99M |
December 31, 2020 | 35.91M |
September 30, 2020 | 31.47M |
June 30, 2020 | 31.81M |
March 31, 2020 | 36.94M |
December 31, 2019 | 35.62M |
September 30, 2019 | 32.57M |
June 30, 2019 | 36.60M |
March 31, 2019 | 37.88M |
December 31, 2018 | 37.05M |
September 30, 2018 | 36.32M |
June 30, 2018 | 32.67M |
Date | Value |
---|---|
March 31, 2018 | 27.61M |
December 31, 2017 | 24.20M |
September 30, 2017 | 23.46M |
June 30, 2017 | 21.81M |
March 31, 2017 | 18.86M |
December 31, 2016 | 17.30M |
September 30, 2016 | 18.38M |
June 30, 2016 | 16.82M |
March 31, 2016 | 16.83M |
December 31, 2015 | 15.34M |
September 30, 2015 | 14.54M |
June 30, 2015 | 14.50M |
March 31, 2015 | 12.64M |
December 31, 2014 | 11.72M |
September 30, 2014 | 10.28M |
June 30, 2014 | 10.27M |
March 31, 2014 | 9.754M |
December 31, 2013 | 9.041M |
September 30, 2013 | 8.082M |
June 30, 2013 | 8.025M |
March 31, 2013 | 6.981M |
December 31, 2012 | 6.30M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
29.86M
Minimum
Dec 2022
50.43M
Maximum
Dec 2023
38.87M
Average
37.56M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Oragenics Inc | 1.754M |
Palatin Technologies Inc | 3.033M |
Oramed Pharmaceuticals Inc | 2.111M |
vTv Therapeutics Inc | 2.569M |
G1 Therapeutics Inc | 15.17M |